VANGUARD GROUP INC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 178 filers reported holding BLUEBIRD BIO INC in Q1 2023. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$17,077,079
-6.8%
5,617,460
+0.8%
0.00%
Q2 2023$18,329,392
+6.3%
5,571,244
+2.7%
0.00%
Q1 2023$17,242,831
-41.6%
5,422,274
+27.1%
0.00%
-100.0%
Q4 2022$29,522,935
+25.7%
4,266,320
+15.0%
0.00%0.0%
Q3 2022$23,482,000
+61.7%
3,709,607
+5.8%
0.00%
Q2 2022$14,518,000
-49.5%
3,506,909
-40.8%
0.00%
-100.0%
Q1 2022$28,749,000
-60.2%
5,927,556
-18.1%
0.00%
-50.0%
Q4 2021$72,263,000
-46.7%
7,233,590
+2.0%
0.00%
-33.3%
Q3 2021$135,475,000
-39.1%
7,089,204
+1.8%
0.00%
-50.0%
Q2 2021$222,615,000
+8.6%
6,961,075
+2.4%
0.01%0.0%
Q1 2021$204,945,000
-26.7%
6,797,519
+5.2%
0.01%
-25.0%
Q4 2020$279,663,000
-18.0%
6,463,232
+2.2%
0.01%
-27.3%
Q3 2020$341,029,000
-8.4%
6,321,228
+3.7%
0.01%
-15.4%
Q2 2020$372,164,000
+108.9%
6,097,060
+57.3%
0.01%
+62.5%
Q1 2020$178,143,000
-46.2%
3,876,042
+2.8%
0.01%
-27.3%
Q4 2019$330,937,000
-4.7%
3,771,360
-0.3%
0.01%
-15.4%
Q3 2019$347,273,000
-28.3%
3,782,102
-0.7%
0.01%
-27.8%
Q2 2019$484,366,000
-37.1%
3,807,915
-22.2%
0.02%
-40.0%
Q1 2019$769,771,000
+61.8%
4,892,714
+2.0%
0.03%
+42.9%
Q4 2018$475,818,000
-29.4%
4,796,557
+3.8%
0.02%
-19.2%
Q3 2018$674,435,000
+2.4%
4,619,413
+10.1%
0.03%
-7.1%
Q2 2018$658,648,000
-7.6%
4,196,547
+0.5%
0.03%
-9.7%
Q1 2018$712,843,000
-1.2%
4,174,775
+3.0%
0.03%
-3.1%
Q4 2017$721,855,000
+42.7%
4,053,085
+10.0%
0.03%
+33.3%
Q3 2017$505,982,000
+35.3%
3,683,881
+3.5%
0.02%
+33.3%
Q2 2017$373,884,000
+27.9%
3,559,102
+10.7%
0.02%
+20.0%
Q1 2017$292,266,000
+54.1%
3,215,246
+4.6%
0.02%
+36.4%
Q4 2016$189,663,000
+2.3%
3,073,953
+12.4%
0.01%0.0%
Q3 2016$185,428,000
+59.8%
2,735,732
+2.0%
0.01%
+57.1%
Q2 2016$116,055,000
+16.3%
2,680,871
+14.2%
0.01%
+16.7%
Q1 2016$99,767,000
-34.5%
2,347,475
-1.0%
0.01%
-40.0%
Q4 2015$152,303,000
-78.9%
2,371,577
-82.4%
0.01%
-63.0%
Q3 2015$720,998,000
+106.3%
13,496,169
+550.3%
0.03%
+12.5%
Q2 2015$349,430,000
+108.6%
2,075,365
+49.6%
0.02%
+118.2%
Q1 2015$167,499,000
+137.6%
1,386,924
+80.5%
0.01%
+120.0%
Q4 2014$70,489,000
+213.0%
768,517
+22.4%
0.01%
+150.0%
Q3 2014$22,521,000
+45.3%
627,673
+56.2%
0.00%
+100.0%
Q2 2014$15,502,000
+206.0%
401,904
+80.4%
0.00%
Q1 2014$5,066,000
+95.0%
222,779
+79.9%
0.00%
Q4 2013$2,598,000
-8.2%
123,817
+18.0%
0.00%
Q3 2013$2,829,000104,9280.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q1 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 5,910,687$24,470,0003.71%
Monaco Asset Management SAM 306,142$1,267,0000.55%
Parametrica Management Ltd 90,105$374,0000.41%
Kamunting Street Capital Management, L.P. 55,200$229,0000.31%
Birchview Capital, LP 98,000$406,0000.30%
Kamunting Street Capital Management, L.P. 35,000$145,0000.20%
PDT Partners, LLC 519,477$2,151,0000.19%
Graham Capital Management, L.P. 781,912$3,237,0000.13%
CAXTON ASSOCIATES LP 220,154$911,0000.09%
Baker Brothers Advisors 2,499,715$10,349,0000.06%
View complete list of BLUEBIRD BIO INC shareholders